Paper42288694
Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities.
Husein A and 7 others. Cancer Gene Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities. Papers, record 42288694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42288694
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Epigenesis, Genetic | Major topic |
| Hepatitis B virus | Major topic |
| Trans-Activators | Major topic |
| Hepatitis B, Chronic | Major topic |
| Humans | |
| Viral Regulatory and Accessory Proteins | |
| Animals |
Source PubMed
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29249332 | Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. | Trends Genet | 2018 | https://conductscience.org/library/papers/29249332 | PubMed |
| 2 | 26160429 | Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin. | Mol Oncol | 2015 | https://conductscience.org/library/papers/26160429 | PubMed |
| 3 | 35629368 | Integrated Analysis of the Altered lncRNA, microRNA, and mRNA Expression in HBV-Positive Hepatocellular Carcinoma. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35629368 | PubMed |
| 4 | 19812400 | MicroRNA expression, survival, and response to interferon in liver cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19812400 | PubMed |
| 5 | 22820290 | MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22820290 | PubMed |
| 6 | 38818956 | Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma. | OMICS | 2024 | https://conductscience.org/library/papers/38818956 | PubMed |
| 7 | 23437062 | Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. | PLoS One | 2013 | https://conductscience.org/library/papers/23437062 | PubMed |
| 8 | 21145824 | Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. | J Hepatol | 2011 | https://conductscience.org/library/papers/21145824 | PubMed |
| 9 | 32295598 | The role of long noncoding RNAs in hepatocellular carcinoma. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32295598 | PubMed |
| 10 | 39868653 | Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma. | J Viral Hepat | 2025 | https://conductscience.org/library/papers/39868653 | PubMed |
| 11 | 34452630 | DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. | Clin Epigenetics | 2021 | https://conductscience.org/library/papers/34452630 | PubMed |
| 12 | 22770212 | Cancer epigenetics: from mechanism to therapy. | Cell | 2012 | https://conductscience.org/library/papers/22770212 | PubMed |
| 13 | 23671639 | Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. | PLoS One | 2013 | https://conductscience.org/library/papers/23671639 | PubMed |
| 14 | 32450266 | Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential. | Antiviral Res | 2020 | https://conductscience.org/library/papers/32450266 | PubMed |
| 15 | 33134907 | Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. | JHEP Rep | 2020 | https://conductscience.org/library/papers/33134907 | PubMed |
| 16 | 27894309 | Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology. | J Transl Med | 2016 | https://conductscience.org/library/papers/27894309 | PubMed |
| 17 | 33573130 | Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver. | Viruses | 2021 | https://conductscience.org/library/papers/33573130 | PubMed |
| 18 | 26983541 | Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. | Nature | 2016 | https://conductscience.org/library/papers/26983541 | PubMed |
| 19 | 29313530 | Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. | Cell Res | 2018 | https://conductscience.org/library/papers/29313530 | PubMed |
| 20 | 31954490 | Epidemiology and surveillance for hepatocellular carcinoma: New trends. | J Hepatol | 2020 | https://conductscience.org/library/papers/31954490 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42288694
GET https://conductscience.org/api/papers/v1/42288694/references?page=2